Summary of Significant Accounting Policies (Details)	12 Months Ended
	Dec. 31, 2021 USD ($) $ / shares shares	Dec. 31, 2020 USD ($) shares	Dec. 31, 2019 USD ($)	Dec. 31, 2021 AUD ($)	Dec. 31, 2020 AUD ($)
Summary of Significant Accounting Policies (Details) [Line Items]
Percentage of net property and equipment	100.00%			100.00%
Due from related parties	$ 604,944			$ 831,984
Cash		$ 165,092			$ 214,240
Property and equipment	431,000	1,103,000
Research and development expense	88,161	0
Prepaid assets and other current assets	11,996	0
Deferred research grant revenue	$ 50,000	$ 24,315
Research and development tax percentage	43.50%	43.50%
Research and development tax incentive	$ 785,761	$ 1,092,345
Other income (expense)	$ 696,714
Research and development additional received			$ 1,132,000
Warrant purchase common shares (in Shares) | shares	400,000	400,000
Aggregate exercise price (in Dollars per share) | $ / shares	$ 0.01
Research and Development [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Research and development tax incentive	$ 966,646	$ 0
Other income (expense)	652,877	0
Research and development additional received	$ 43,837	0
Minimum [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Estimated useful lives	two
Maximum [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Estimated useful lives	five
Research and Development Expense [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Research and development expense	$ 997,801	$ 0